INmune Bio Corp (INMB) Company Long-Term Loans and Borrowings
INmune Bio, Inc. (INMB) is currently spending funds on clinical trials without stable profit sources, meaning financing relies on external investments. However, the future scalability of the business is immense: patenting formulas will allow for a rapid recovery of R&D costs. This chart shows that long-term debt stands at 0.00. Meanwhile, the development of immunotherapy remains independent of market cycles, relying solely on scientific achievements.
Analytical breakdowns for INmune Bio Corp (INMB)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Fundamental company valuation:inmunebio.com (INMB)
Institutional interest in INmune Bio, Inc. (INMB) shares depends directly on the company's ability to fund the development of its macrophage therapy platform without incurring a critical debt load. By analyzing the dynamics of the business's long-term borrowed capital, investors assess total liabilities with maturities exceeding one year, which allows them to determine the financial stability of the ecosystem during the implementation of complex clinical protocols and confirms the asset's reliability.
Competitor analysis for INmune Bio, Inc.
argenx.com - Company Long-Term Debts|Company Long-Term Debt BioNTech (BNTX)|ABVX: Company Long-Term Loans and Borrowings|ADMA (ADMA Bio) - Company Long-Term Debt|Protagonist Corp (PTGX) - Company Long-Term Liabilities|IMVT (Immunovant, Inc.) - Company Long-Term Debts|Company Long-Term Debts kiniksa.com (KNSA)|Grifols (GRFS) - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings Adaptive Biotech (ADPT)|Company Long-Term Debts CLDX|Aurinia Corp - Long-Term Debt Volume|BCRX: Company Long-Term Debt|VERA: Company Long-Term Liabilities|DNTH (Dianthus Therapeutics, Inc.) - Company Long-Term Debt|Company Long-Term Liabilities Pharvaris NV|ABCL (AbCellera Biologics) - Company Long-Term Liabilities|Company Long-Term Debts TRML|Company Long-Term Debt Precigen, Inc. PGEN|Company Long-Term Indebtedness pharming.com (PHAR)|NKTR: Company Long-Term Debts|Long-Term Debt Upstream Bio, Inc. UPB|Company Long-Term Debts ZBIO (Zenas Biopharma, Inc.)|IMNM: Long-Term Debt Volume|Company Long-Term Debt Gossamer Bio, Inc.|KALV (kalvista.com) - Company Long-Term Indebtedness|Company Long-Term Debt SEPN|Company Long-Term Liabilities Pieris Pharma (PVLA)|Company Long-Term Liabilities SVRA|Company Long-Term Debts RIGL (Rigel Corp)|ANAB - Company Long-Term Debt|Company Long-Term Indebtedness astriatx.com ATXS|ENGN (enGene) - Company Long-Term Debts|rapt.com (RAPT) - Long-Term Debt|Company Long-Term Liabilities aerovatetx.com JBIO|Aclaris Therapeutics, Inc (ACRS) - Company Long-Term Loans and Borrowings|Company Long-Term Debts Kyverna Therapeutics|Company Long-Term Debt tizianalifesciences.com|CABA (Cabaletta Bio) - Company Long-Term Debts|Long-Term Debt Volume VTYX (Ventyx Biosciences Inc.)|THTX: Company Long-Term Debt|AVTX - Long-Term Debt|Company Long-Term Liabilities Eledon Pharmaceuticals (ELDN)|AGEN - Company Long-Term Loans and Borrowings|Climb Bio - Company Long-Term Debts|ZURA (zurabio.com) - Long-Term Debt Volume|Company Long-Term Debt aTyr (ATYR)|Company Long-Term Indebtedness Adagene Corp|Company Long-Term Debts IMA (ImageneBio Inc)|Company Long-Term Liabilities shattucklabs.com STTK|Company Long-Term Liabilities EQ|Long-Term Debt Volume Connect Biopharma Holdings CNTB|Company Long-Term Debts IMUX (Immunic Inc)|ATRA: Long-Term Debt Volume|Company Long-Term Debt inflarx.de|XFOR (x4pharma.com) - Company Long-Term Indebtedness|Company Long-Term Debt ACET|Company Long-Term Liabilities Celularity Corp|Company Long-Term Debts Barinthus Bio (BRNS)|Company Long-Term Debt KZR (Kezar Life Sciences Inc)|SAB Biotherapeutics (SABS) - Company Long-Term Debt|Long-Term Liabilities akaritx.com AKTX|Company Long-Term Debts Enlivex Therapeutics, Ltd. (ENLV)|QTTB - Company Long-Term Loans and Borrowings|GOVX: Company Long-Term Debts|EDSA (Edesa Biotech Corp) - Company Long-Term Debts|IBIO - Company Long-Term Debt|Company Long-Term Loans and Borrowings CARM|Company Long-Term Debt XTLB (XTL Biopharmaceuticals Ltd.)|Company Long-Term Liabilities boltbio.com (BOLT)|Company Long-Term Debts HCWB (HCW Biologics)|APVO - Company Long-Term Debts|Company Long-Term Liabilities AIM ImmunoTech (AIM)|ADTX - Company Long-Term Loans and Borrowings|GRI Bio - Company Long-Term Debts|XRTX (XORTX Therapeutics Inc) - Long-Term Debt Volume|Company Long-Term Debt HIND|Company Long-Term Liabilities REVB|Company Long-Term Debt INDP (Indaptus Therapeutics)|Company Long-Term Liabilities scinai.com SCNI|Company Long-Term Liabilities CALI (CalciMedica)|Affimed NV - Company Long-Term Debts|Allakos Therapeutics (ALLK) - Company Long-Term Debt|HOOK - Company Long-Term Indebtedness|Company Long-Term Debts IGMS|iteostherapeutics.com (ITOS) - Long-Term Debt|OCEA: Company Long-Term Debts|Long-Term Debt Volume TCBP|Company Long-Term Debt Third Harmonic Bio, Inc THRD